Skip to main content

Table 1 Demographic and clinical characteristic of patients

From: Characteristics and outcome of influenza-associated encephalopathy/encephalitis among children in a tertiary pediatric hospital in Italy, 2017–2019

Age (month) [median (IQR)]: 27 (7–48)

 0- ≤ 2 years [n (%)]:

6 (40%)

 2–10 years [n (%)]:

9 (60%)

Sex

 Male [n (%)]:

4 (26.7%)

 Female [n (%)]:

11 (73.3%)

Comorbid disease [n (%)]:

5 (33.3%)

 Chronic neurological diseases: [n (%)]:

4 (26.7%)

 Congenital heart disease [n (%)]:

1 (6.7%)

Seasonal influenza vaccination:

none

Time between flu-like symptoms and neurological manifestations

  [median (IQR)]:

1 day (0 h-3 days)

Unit or department of admission [n (%)]

 Pediatric department:

14 (93.3%)

 Pediatric intensive care unit:

1 (6.7%)

Duration of hospitalization

  [median (IQR)]:

9 days (7–12 days)

Clinical presentation at admission [n (%)]

 Fever:

13 (86.7%)

  • Maximum [median (IQR)]

38.7 (37.6–39.2) °C

 Neurologic manifestations:

15 (100%)

  • Seizures:

6 (40%)

  • Altered consciousness:

8 (53.3%)

  • Ataxia:

1 (6.7%)

 Respiratory manifestations:

11 (73.3%)

  • Cough:

7 (46.7%)

  • Dyspnea

4 (26.7%)

Other influenza-related complications [n (%)]

 Respiratory failure:

4 (26.7%)

 Liver impairment:

1 (6.7%)

 PICU admission:

4 (26.7%)

 Days in PICU [median (IQR)]:

5.5 (4.25–15)